IP Verse

Konig Szynka Tilmann Von Renesse opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Konig Szynka Tilmann Von Renesse

Patent Number:
EP4108782
Title:
Compositions And Methods For Analyte Detection
Applicant:
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Opposition Date:
Mar 7, 2024
Patent Number:
EP3265122
Title:
Combination Of A Pd-1 Antagonist And Eribulin For Treating Cancer
Applicant:
EISAI R&D MANAGEMENT CO., LTD.
Opposition Date:
Jan 23, 2023
Patent Number:
EP3827845
Title:
Subcutaneous Formulations Of Anti-Cd38 Antibodies And Their Uses
Applicant:
JANSSEN BIOTECH, INC.
Opposition Date:
Dec 27, 2022
Patent Number:
EP3763820
Title:
Retroviral Transduction Using Poloxamers
Applicant:
HELMHOLTZ ZENTRUM MÜNCHEN - DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH)
Opposition Date:
Sep 22, 2022
Patent Number:
EP3521422
Title:
Substantially Animal Protein-Free Recombinat Furin And Methods For Producing Same
Applicant:
BAXALTA GMBH
Opposition Date:
Jul 6, 2022
Patent Number:
EP3498734
Title:
Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating Cancer
Applicant:
MERCK SHARP & DOHME CORP.
Opposition Date:
Jun 1, 2022
Patent Number:
EP3047013
Title:
Methods And Systems For Processing A Cell Culture
Applicant:
GENZYME CORPORATION
Opposition Date:
May 18, 2022
Patent Number:
EP3440329
Title:
Fuel Exchange System And Fuel Supply System For Fuel Systems
Applicant:
BEFINAL GMBH
Opposition Date:
Nov 17, 2021
Patent Number:
EP3218406
Title:
Binding Molecules Specific For Cd73 And Uses Thereof
Applicant:
MEDIMMUNE LIMITED
Opposition Date:
Nov 12, 2021
Patent Number:
EP3616720
Title:
Pharmaceutical Composition For Cancer Treatment
Applicant:
OSAKA UNIVERSITY
Opposition Date:
Oct 14, 2021

Competitors of Konig Szynka Tilmann Von Renesse

MERCK SHARP & DOHME CORP.

AMGEN INC.

F. HOFFMANN-LA ROCHE AG

Want to track Konig Szynka Tilmann Von Renesse?

Feel free to send us a message here and we will get back to you